Hemostatic profile and thromboembolic risk in healthy dogs treated with prednisone: A randomized controlled trial

13Citations
Citations of this article
63Readers
Mendeley users who have this article in their library.

Abstract

Background: Thrombosis has been associated to some diseases like hyperadrenocorticism (HAC). Several drugs can alter the balance, such as the corticosteroid prednisone, used mainly for its anti-inflammatory and immunosuppressive effects. It is known that hypercortisolism can stimulate thrombi formation by increasing coagulation factors and decreasing fibrinolysis. However it is not known how prednisone administration affects hemostasis in dogs and if it is dose dependent. The aim of this study, therefore, was to demonstrate the effects of prednisone administration on dogs' hemostatic profile.Results: Significant decrease of antithrombin levels was observed in both groups (anti-inflammatory and immunosuppressive doses) after 15 days of treatment. An increase of platelet aggregation was observed in dogs receiving immunosuppressive doses of prednisone (Group II).Conclusions: From the results obtained in our study, it is not possible to infer that hypercortisolism can increase the thromboembolic risk, despite the decreased anticoagulant factors (antithrombin levels). © 2013 Romão et al.; licensee BioMed Central Ltd.

Cite

CITATION STYLE

APA

Romão, F. G., Campos, E. F., Mattoso, C. R. S., & Takahira, R. K. (2013). Hemostatic profile and thromboembolic risk in healthy dogs treated with prednisone: A randomized controlled trial. BMC Veterinary Research, 9. https://doi.org/10.1186/1746-6148-9-268

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free